Welcome to our dedicated page for Aemetis SEC filings (Ticker: AMTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Carbon-credit revenues, dairy digester build-outs and dual-continent operations make Aemetis Inc. (AMTX) filings anything but straightforward. If you have ever combed through a 300-page annual report hunting for Low Carbon Fuel Standard revenue or segment data from the company’s Indian biodiesel plant, you know the challenge.
Stock Titan removes that friction. Our AI-powered summaries turn dense 10-K text into plain-language insights, while real-time alerts flag each new Aemetis quarterly earnings report 10-Q filing and every Aemetis 8-K material events explained. Want instant visibility into Aemetis insider trading Form 4 transactions? We surface Form 4 details the moment they hit EDGAR, linking trades to upcoming credit milestones so you can monitor Aemetis executive stock transactions Form 4 in context.
Explore every document type in one place:
- 10-K: Cash-flow swings and LCFS credit economics—Aemetis annual report 10-K simplified.
- 10-Q: Quarterly production yields and RNG pipeline spend—Aemetis earnings report filing analysis.
- 8-K: Plant outages, new offtake agreements, tax-credit sales.
- DEF 14A: Aemetis proxy statement executive compensation with AI comparisons to peer renewables.
- Form 4: Aemetis Form 4 insider transactions real-time alerts.
Use cases professionals rely on: compare segment margins quarter-over-quarter, trace capital expenditures on biogas digesters, and verify carbon-intensity assumptions—understanding Aemetis SEC documents with AI saves hours and sharpens decisions. From the first dairy RNG project note to the latest share-sale disclosure, every AMTX filing is here, explained simply.
Barton Francis P, identified as a director of Aemetis, Inc. (AMTX), reported multiple open-market sales of the issuer's common stock on 08/14/2025. Four sale transactions at a price of $2.5335 per share disposed of 1,300, 12,152, 5,000 and 8,000 shares, totaling 26,452 shares sold. The filings show the reporting person’s beneficial ownership decreased from 233,670 shares pre-sale (as reflected after the first line) to 208,518 shares following the last reported transaction. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
A Form 144 notice shows a proposed sale of 26,452 shares of common stock of the issuer via Raymond James & Associates on 08/14/2025, with an aggregate market value of $66,923.56. The shares reported for sale were granted as restricted stock units (RSUs) by the issuer on 01/07/2021 (1,300 shares), 04/08/2021 (12,152 shares), 11/18/2021 (5,000 shares), and 08/18/2022 (8,000 shares). The filer reports no securities sold during the past 3 months and indicates payment for these proposed sales will be cash. The filing includes the standard representation that the seller does not possess undisclosed material information about the issuer.
FAQ
What is the current stock price of Aemetis (AMTX)?
What is the market cap of Aemetis (AMTX)?
